IMAX Co. (NYSE:IMAX - Free Report) - Analysts at Roth Capital upped their FY2027 EPS estimates for IMAX in a research report issued to clients and investors on Wednesday, April 9th. Roth Capital analyst E. Handler now anticipates that the company will post earnings per share of $1.28 for the year, up from their prior forecast of $1.24. The consensus estimate for IMAX's current full-year earnings is $0.91 per share.
Other research analysts have also recently issued research reports about the company. Benchmark reiterated a "buy" rating and set a $30.00 price objective on shares of IMAX in a research note on Thursday, April 10th. JPMorgan Chase & Co. lowered their price target on IMAX from $27.00 to $26.00 and set a "neutral" rating on the stock in a report on Friday. Wells Fargo & Company boosted their target price on IMAX from $26.00 to $32.00 and gave the stock an "overweight" rating in a research report on Thursday, February 20th. Macquarie boosted their price objective on shares of IMAX from $28.00 to $30.00 and gave the company an "outperform" rating in a report on Thursday, February 20th. Finally, Barrington Research raised their target price on shares of IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $30.56.
View Our Latest Research Report on IMAX
IMAX Price Performance
IMAX stock traded down $0.10 during mid-day trading on Thursday, reaching $21.54. 342,236 shares of the company traded hands, compared to its average volume of 754,456. IMAX has a 52-week low of $14.94 and a 52-week high of $27.77. The firm's 50 day moving average price is $25.29 and its 200 day moving average price is $24.18. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of 43.96, a P/E/G ratio of 1.49 and a beta of 0.91.
IMAX (NYSE:IMAX - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.14). The company had revenue of $92.67 million during the quarter, compared to analysts' expectations of $104.08 million. IMAX had a return on equity of 8.60% and a net margin of 7.40%.
Institutional Investors Weigh In On IMAX
Institutional investors have recently made changes to their positions in the company. Principal Financial Group Inc. raised its position in IMAX by 69.3% in the 4th quarter. Principal Financial Group Inc. now owns 103,946 shares of the company's stock worth $2,661,000 after purchasing an additional 42,562 shares during the period. Intech Investment Management LLC lifted its stake in shares of IMAX by 116.1% during the 4th quarter. Intech Investment Management LLC now owns 21,589 shares of the company's stock worth $553,000 after acquiring an additional 11,597 shares during the last quarter. Raymond James Financial Inc. purchased a new position in IMAX during the 4th quarter valued at $9,143,000. Savant Capital LLC purchased a new stake in IMAX in the fourth quarter worth $249,000. Finally, Lord Abbett & CO. LLC bought a new stake in shares of IMAX during the third quarter worth $6,322,000. Institutional investors own 93.51% of the company's stock.
IMAX Company Profile
(
Get Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Read More

Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.